3 Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Deepak Fertilisers and Studds Accessories

Emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks give investors exposure to medicines, industrial chemicals and safety gear. Volumes, pricing and margins decide how much of that demand turns into profit.

This list covers three emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks: Lincoln Pharmaceuticals for formulations sold in India and emerging export markets, Deepak Fertilisers for industrial chemicals, mining chemicals and fertilisers and Studds Accessories for motorcycle helmets and riding accessories sold in India and overseas. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks?

Emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks as of the 14 Oct 2026 close.

Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P/E multiples.

Why Do Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks Have a Strong Roadmap in India?

Emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks have a strong roadmap in India because export formulation demand, mining and farm chemical use and two-wheeler ownership keep adding volumes for these firms. Three drivers stand out.

• Formulation exports: Emerging markets buy affordable medicines.
• Mining and farms: Miners and growers buy specialty chemicals and fertilisers.
• Two-wheeler riders: Safety rules and rising incomes lift helmet demand.

Lincoln Pharmaceuticals: Formulations for India and Export Markets Build the Next Leg

Lincoln Pharma's roadmap rests on formulations sold in India and emerging export markets, with a broad product list supporting revenue.

Revenue grew from Rs 482.12 crore in FY22 to Rs 704.48 crore in FY26, a 46.1% rise, and FY26 revenue was 9.1% higher than FY25. FY26 net profit rose 6.7% to Rs 87.89 crore. Over four years, net profit rose from Rs 69.36 crore in FY22 to Rs 87.89 crore. In Q1 FY27, revenue grew 19.0% to Rs 201.54 crore, and net profit rose 30.9% to Rs 36.23 crore.

Debt to equity is 0.01 and return on equity is 11.60%. The dividend yield is 0.32%. At a P/E of 11.64 against an industry P/E of 37.59, the stock trades below its industry multiple.

What to watch: The P/E of 11.64 against an industry P/E of 37.59 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Deepak Fertilisers: Industrial Chemicals and Fertilisers Build the Next Leg

Deepak Fertilisers' roadmap rests on industrial chemicals, mining chemicals and fertilisers, with a mix of industrial and farm demand supporting revenue.

Revenue grew from Rs 7,707.22 crore in FY22 to Rs 11,609.03 crore in FY26, a 50.6% rise, and FY26 revenue was 12.1% higher than FY25. FY26 net profit was Rs 738.76 crore. In Q1 FY27, revenue grew 21.6% to Rs 3,262.21 crore. Operating margin was 15.53% in FY26 and 26.15% in Q1 FY27 against 20.19% a year earlier.

Debt to equity is 0.83 and return on equity is 10.77%. FY26 operating cash flow was Rs 206.23 crore against capital expenditure of Rs 1,570.42 crore. Deepak Fertilisers paid a dividend of Rs 10 per share for FY26, a yield of 0.72%. At a P/E of 17.80 against an industry P/E of 36.60, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 26.15% against 15.53% for FY26, so margin stability is the figure to follow as volumes grow.

Studds Accessories: Helmets and Riding Gear Build the Next Leg

Studds' roadmap rests on motorcycle helmets and riding accessories sold in India and overseas, with rising two-wheeler use and safety awareness supporting volumes.

Revenue grew from Rs 467.98 crore in FY22 to Rs 645.75 crore in FY26, a 38.0% rise, and FY26 revenue was 8.4% higher than FY25. FY26 net profit rose 18.7% to Rs 82.65 crore. Over four years, net profit rose from Rs 28.64 crore in FY22 to Rs 82.65 crore. In Q1 FY27, revenue grew 13.8% to Rs 172.92 crore. Operating margin was 21.25% in FY26.

Debt to equity is 0.02 and return on equity is 15.80%. FY26 operating cash flow was Rs 86.42 crore against capital expenditure of Rs 47.04 crore. Studds paid a dividend of Rs 3 per share for FY26, a yield of 0.72%. At a P/E of 21.92 against an industry P/E of 36.50, the stock trades below its industry multiple.

What to watch: The P/E of 21.92 against an industry P/E of 36.50 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Best Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks in India: Lincoln Pharma vs Deepak Fertilisers vs Studds on Key Financials

Among the best emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks in India, Lincoln Pharma leads on the lowest P/E and the lowest debt to equity; Deepak Fertilisers leads on FY26 revenue growth and Q1 FY27 revenue growth; Studds leads on return on equity. The table puts the numbers side by side.

Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks and shortlist emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks

Risks to Consider Before Investing in Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks

• Consumer demand: Spending patterns can shift sales between quarters.
• Input costs: Changes in raw material prices can affect margins.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Lincoln Pharma, Deepak Fertilisers and Studds live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare, chemicals and consumer stocks cover formulations, chemicals and helmets. Lincoln Pharma leads on the lowest P/E and the lowest debt to equity; Deepak Fertilisers leads on FY26 revenue growth and Q1 FY27 revenue growth; Studds leads on return on equity.

Across emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks to buy discussed here.

FAQs on Emerging-Market Formulation Firm, Fertiliser Chemical Maker and Helmet Brand Stocks

Which are the best emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks in India with a strong roadmap?

Ans. Lincoln Pharmaceuticals, Deepak Fertilisers and Studds Accessories stand out for their roadmaps in formulations, chemicals and helmets. FY26 revenue growth was 9.1% at Lincoln Pharma, 12.1% at Deepak Fertilisers and 8.4% at Studds, and return on equity ranges from 10.77% to 15.80%.

Is Lincoln Pharmaceuticals a good stock to buy now?

Ans. Lincoln Pharmaceuticals has a debt to equity ratio of 0.01, a return on equity of 11.60% and a P/E of 11.64 against an industry P/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Lincoln Pharma, Deepak Fertilisers and Studds?

Ans. The P/E ratio is 11.64 for Lincoln Pharma (industry 37.59), 17.80 for Deepak Fertilisers (industry 36.60) and 21.92 for Studds (industry 36.50). All of them trade below the industry multiple.

Which of these emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks has the highest return on equity?

Ans. Studds Accessories has the highest return on equity at 15.80%, followed by Lincoln Pharmaceuticals at 11.60% and Deepak Fertilisers at 10.77%.

What are the risks of investing in emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks?

Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.

How did Lincoln Pharma, Deepak Fertilisers and Studds perform in Q1 FY27?

Ans. Lincoln Pharmaceuticals reported revenue of Rs 201.54 crore, up 19.0% year on year, and net profit rose 30.9% to Rs 36.23 crore. Deepak Fertilisers reported revenue of Rs 3,262.21 crore, up 21.6% year on year. Studds Accessories reported revenue of Rs 172.92 crore, up 13.8% year on year.

Do emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 0.32% for Lincoln Pharma, 0.72% for Deepak Fertilisers and 0.72% for Studds, based on dividends declared for FY26.

How can I invest in emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks in India?

Ans. You can buy emerging-market formulation firm, fertiliser chemical maker and helmet brand stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.